MXRA5
Basic information
Region (hg38): X:3308565-3346652
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MXRA5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 10 | 14 | 24 | |||
missense | 148 | 14 | 13 | 175 | ||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 2 | 2 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 148 | 24 | 27 |
Variants in MXRA5
This is a list of pathogenic ClinVar variants found in the MXRA5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
X-3309826-C-G | not specified | Uncertain significance (Apr 20, 2024) | ||
X-3309969-G-A | not specified | Uncertain significance (Jan 03, 2024) | ||
X-3309982-G-C | not specified | Uncertain significance (Feb 16, 2023) | ||
X-3309988-G-A | not specified | Uncertain significance (Mar 08, 2024) | ||
X-3310051-C-A | not specified | Uncertain significance (Mar 20, 2024) | ||
X-3310179-T-C | Likely benign (Nov 01, 2022) | |||
X-3310200-CGTCCCTGCCCAGCCCCG-TGTCCCTGCCCAGCTGCA | not provided (-) | |||
X-3310282-T-C | not specified | Uncertain significance (Dec 20, 2023) | ||
X-3310311-A-C | not specified | Uncertain significance (Sep 06, 2022) | ||
X-3310337-A-C | Benign (Jan 04, 2022) | |||
X-3310337-A-T | Benign (Mar 29, 2018) | |||
X-3310348-G-A | not specified | Uncertain significance (Jun 06, 2023) | ||
X-3310354-C-T | not specified | Uncertain significance (Aug 21, 2023) | ||
X-3310360-G-A | not specified | Conflicting classifications of pathogenicity (Aug 02, 2023) | ||
X-3310368-C-G | Uncertain significance (Sep 22, 2023) | |||
X-3310370-G-A | Benign (Jan 29, 2022) | |||
X-3310390-C-T | Benign (Apr 16, 2018) | |||
X-3310439-C-A | not specified | Uncertain significance (May 30, 2023) | ||
X-3310456-C-A | not specified | Uncertain significance (Jan 22, 2024) | ||
X-3310464-T-C | not specified | Uncertain significance (Jul 12, 2023) | ||
X-3310503-G-A | not specified | Uncertain significance (Jul 06, 2021) | ||
X-3310535-C-T | Likely benign (Apr 01, 2023) | |||
X-3310563-G-A | not specified | Uncertain significance (Aug 02, 2022) | ||
X-3310612-G-C | Benign (May 20, 2020) | |||
X-3310622-G-C | Benign (May 20, 2020) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MXRA5 | protein_coding | protein_coding | ENST00000217939 | 6 | 38077 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0430 | 0.957 | 125710 | 17 | 21 | 125748 | 0.000151 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.728 | 1213 | 1.14e+3 | 1.06 | 0.0000928 | 18435 |
Missense in Polyphen | 359 | 375.13 | 0.957 | 5770 | ||
Synonymous | -0.195 | 481 | 476 | 1.01 | 0.0000424 | 5876 |
Loss of Function | 5.12 | 14 | 55.0 | 0.255 | 0.00000413 | 996 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000680 | 0.000592 |
Ashkenazi Jewish | 0.00134 | 0.000993 |
East Asian | 0.000146 | 0.000109 |
Finnish | 0.000126 | 0.0000924 |
European (Non-Finnish) | 0.0000993 | 0.0000703 |
Middle Eastern | 0.000146 | 0.000109 |
South Asian | 0.000216 | 0.000131 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: In kidney, has anti-inflammatory and anti-fibrotic properties by limiting the induction of chemokines, fibronectin and collagen expression in response to TGB1 and pro-inflammatory stimuli. {ECO:0000269|PubMed:27599751}.;
- Disease
- DISEASE: Lung cancer (LNCR) [MIM:211980]: A common malignancy affecting tissues of the lung. The most common form of lung cancer is non-small cell lung cancer (NSCLC) that can be divided into 3 major histologic subtypes: squamous cell carcinoma, adenocarcinoma, and large cell lung cancer. NSCLC is often diagnosed at an advanced stage and has a poor prognosis. {ECO:0000269|PubMed:22696596}. Note=Disease susceptibility may be associated with variations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.0949
Intolerance Scores
- loftool
- 0.310
- rvis_EVS
- 1.57
- rvis_percentile_EVS
- 95.68
Haploinsufficiency Scores
- pHI
- 0.226
- hipred
- N
- hipred_score
- 0.384
- ghis
- 0.428
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.135
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- response to transforming growth factor beta
- Cellular component
- collagen-containing extracellular matrix;extracellular exosome
- Molecular function
- extracellular matrix structural constituent